JPS61165363A - Cinnamic acid amide derivative and production thereof - Google Patents

Cinnamic acid amide derivative and production thereof

Info

Publication number
JPS61165363A
JPS61165363A JP650385A JP650385A JPS61165363A JP S61165363 A JPS61165363 A JP S61165363A JP 650385 A JP650385 A JP 650385A JP 650385 A JP650385 A JP 650385A JP S61165363 A JPS61165363 A JP S61165363A
Authority
JP
Japan
Prior art keywords
reaction
formula
compound
acid amide
dimethylaminoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP650385A
Other languages
Japanese (ja)
Inventor
Harushige Fujita
藤田 治重
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUTAMI KIMIO
Original Assignee
FUTAMI KIMIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUTAMI KIMIO filed Critical FUTAMI KIMIO
Priority to JP650385A priority Critical patent/JPS61165363A/en
Publication of JPS61165363A publication Critical patent/JPS61165363A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

NEW MATERIAL:N-(2-Dimethylaminoethyl)-N-(o-mercaptophenyl)-p-methoxy-alpha- acetoxycinnamic acid amide shown by the formula I and its acid addition salt. USE:Useful as an intermediate for synthesizing a benzothiazepine derivative. The compound is useful as an antidepressives, tranaquilizer, coronary vasodilator, etc. PREPARATION:A compound shown by the formula II (X is OH, or halogen) or 2-N-(2-dimethylaminoethyl)aminothiophenol shown by the formula III are subjected to a condensation reaction through dehydration or dehydrohalogenation reaction, to give a compound shown by the formula I. The condensation reaction through dehydration is carried out in an aprotic solvent in the presence of a condensation agent such as N,N'-dicyclohexylcarbodiimide, etc., at -20-50 deg.C, and the dehydrohalogenation is done in an aprotic solvent in the presence of a base preferably pyridine, etc., at -30-50 deg.C.

Description

【発明の詳細な説明】 i−L−1−1 本発明は、ケイ皮酸アミド誘導体及びその製造法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION i-L-1-1 The present invention relates to a cinnamic acid amide derivative and a method for producing the same.

1里11し【 本発明の、ケイ皮酸アミド誘導体は、文献未載の新規化
合物であり、式 で表わされるN−(2−ジメチルアミノエチル)−N−
(o−メルカプトフェニル)−p−メトキシ−α−7セ
トキシケイ皮酸アミド及びその酸付加塩である。
[The cinnamic acid amide derivative of the present invention is a new compound that has not been described in any literature, and is represented by the formula N-(2-dimethylaminoethyl)-N-
(o-mercaptophenyl)-p-methoxy-α-7cetoxycinnamic acid amide and its acid addition salt.

本発明のケイ皮酸アミド誘導体は、閉環反応により容易
に式 で表わされる2−(4−メトキシフェニル)−3−アセ
トキシ−5−(2−ジメチルアミノエチル)−2.3−
ジヒドロ−1.5−ベンゾチアゼピン−4 (5H)−
オンを生成する。従って、本発明のケイ皮酸アミド誘導
体は、式(IF)の化合物及びその酸付加塩の製造中間
体として有用である。
The cinnamic acid amide derivative of the present invention is easily expressed by the formula 2-(4-methoxyphenyl)-3-acetoxy-5-(2-dimethylaminoethyl)-2.3-
Dihydro-1,5-benzothiazepine-4 (5H)-
Generate on. Therefore, the cinnamic acid amide derivative of the present invention is useful as an intermediate for producing the compound of formula (IF) and its acid addition salt.

式(n)の化合物及びその酸付加塩は、ベンゾチアゼピ
ン誘導体の中でも特に重要な医薬品であり、抗抑うつ剤
、精神神経安定剤、冠状血管拡張剤等として臨床に供さ
れている。
The compound of formula (n) and its acid addition salt are particularly important pharmaceuticals among benzothiazepine derivatives, and are used clinically as antidepressants, psychoneurol stabilizers, coronary vasodilators, and the like.

本発明の式CI)の化合物は、例えば下記反応工程式A
に従って製造される。
Compounds of formula CI) according to the invention can be used, for example, in the following reaction scheme A
Manufactured according to.

く反応工程式A〉 脱水縮合反応又は 〔上記一般式(III)中、Xは水酸基又はハロゲン原
子を示す。〕 即ち、一般式(III)で表わされる化合物と式(rV
)で表わされる2−N− (2−ジメチルアミノエチル
)アミノチオフェノールとを、脱水縮合反応又は脱ハロ
ゲン化水素反応に付することにより目的の式CI)の化
合物が得られる。
Reaction Scheme A> Dehydration condensation reaction or [In the above general formula (III), X represents a hydroxyl group or a halogen atom. ] That is, the compound represented by the general formula (III) and the formula (rV
2-N-(2-dimethylaminoethyl)aminothiophenol represented by ) is subjected to a dehydration condensation reaction or a dehydrohalogenation reaction to obtain the desired compound of formula CI).

上記脱水縮合反応の反応条件としては、特に限定されず
、この種の反応の通常の条件と同様で良い。具体的には
、Xが水酸基の化合物(lira )に対して化合物(
TV)を通常0.5〜2倍モル程度の割合で用い、非プ
ロトン性溶媒中で反応させれば良い。非プロトン性溶媒
としては、例えば塩化メチレン、ジオキサン、アセトニ
トリル、1.1゜2−トリクロルエタン、クロロホルム
、ジメチルホルムアミド、ジメチルスルホキシド等を挙
げることができ、これらの少なくとも1種を用いる。
The reaction conditions for the dehydration condensation reaction are not particularly limited and may be the same as usual conditions for this type of reaction. Specifically, for a compound where X is a hydroxyl group (lira), a compound (
TV) at a ratio of usually about 0.5 to 2 times the mole, and the reaction may be carried out in an aprotic solvent. Examples of the aprotic solvent include methylene chloride, dioxane, acetonitrile, 1.1°2-trichloroethane, chloroform, dimethylformamide, dimethyl sulfoxide, and at least one of these is used.

反応は、通常、縮合剤の存在下に行なうのが好ましい。The reaction is usually preferably carried out in the presence of a condensing agent.

縮合剤としては、例えばN、N’ −ジシクロヘキシル
カルボジイミド ゾール、1−エチル−3− (3’ −ジメチルアミノ
プロピル〉カルボジイミド、これらの塩酸塩等を挙げる
ことができる。縮合剤の使用量は、化合物Cma )に
対して通常0.5倍モル以上程度、特に好ましくは1〜
4倍モル程度とするのが良い。
Examples of the condensing agent include N,N'-dicyclohexylcarbodiimidozole, 1-ethyl-3-(3'-dimethylaminopropyl)carbodiimide, and hydrochlorides thereof.The amount of the condensing agent used is determined by the amount of the compound. Cma), usually about 0.5 times or more in mole, particularly preferably 1 to
It is preferable to set the amount to about 4 times the mole.

反応雰囲気は、特に限定されないが、窒素、二酸化炭素
、アルゴン等の不活性雰囲気であるのが好ましい。反応
温度は、特に限定されないが、通常=20〜50℃程度
とするのが適当である。本反応は、通常1〜24時間程
時間路了し、目的化合物(I)が生成する。
The reaction atmosphere is not particularly limited, but is preferably an inert atmosphere such as nitrogen, carbon dioxide, or argon. The reaction temperature is not particularly limited, but it is usually appropriate to set it to about 20 to 50°C. This reaction usually takes about 1 to 24 hours to produce the target compound (I).

また上記脱ハロゲン化水素反応の反応条件としては、特
に限定されず、この種の反応の通常の条件と同様で良い
。具体的には、Xが弗素、塩素、臭素、沃素等のハロゲ
ン原子である化合物(Ilrb )に対して化合物(r
V)を通常0.5〜2倍モル程度の割合で用い、前記非
プロトン性溶媒中で反応させれば良い。反応は、無触媒
下でも触媒存在下でも進行する。無触媒下で反応させた
場合には、生成物が塩酸塩等のハロゲン化水素付加塩と
して得られる。触媒を用いる場合には、通常例えばピリ
ジン、コリジン、トリエチルアミン等の塩基性触媒の存
在下に行なうのが好ましい。触媒を使用する場合の使用
量は、化合物(Il[b )に対して通常0.5倍モル
以上程度、特に好ましくは1〜2倍モル程度とするのが
良い。反応は、前記不活性雰囲気中で行なうのが好まし
い。反応温度は、特に限定されないが、通常−30〜5
0℃程度とするのが適当である。本反応は、通常10分
〜24時間程度で終了し、目的化合物(I)が生成する
The reaction conditions for the dehydrohalogenation reaction are not particularly limited, and may be the same as usual conditions for this type of reaction. Specifically, the compound (r
V) may be used in a ratio of usually about 0.5 to 2 times the mole, and the reaction may be carried out in the aprotic solvent. The reaction proceeds both in the absence of a catalyst and in the presence of a catalyst. When the reaction is carried out without a catalyst, the product is obtained as a hydrohalide addition salt such as a hydrochloride. When a catalyst is used, it is usually preferable to carry out the reaction in the presence of a basic catalyst such as pyridine, collidine, or triethylamine. When a catalyst is used, the amount used is usually about 0.5 times or more, particularly preferably about 1 to 2 times, by mole, relative to compound (Il[b)]. Preferably, the reaction is carried out in the inert atmosphere. The reaction temperature is not particularly limited, but is usually -30 to 5
It is appropriate to set the temperature to about 0°C. This reaction usually ends in about 10 minutes to 24 hours, and the target compound (I) is produced.

生成した目的化合物CI)は、慣用の分離精製手段、例
えば再結晶、各種クロマトグラフィー等により容易に単
離できる。かくして、目的化合物(I)を高収率で得る
ことができる。
The produced target compound CI) can be easily isolated by conventional separation and purification means such as recrystallization, various chromatography, etc. In this way, the target compound (I) can be obtained in high yield.

本発明においては、上記で得られる目的化合物(I)を
、必要に応じて、常法によって、塩酸塩、硫酸塩、硝酸
塩等の酸付加塩にすることもできる。
In the present invention, the target compound (I) obtained above can be converted into an acid addition salt such as a hydrochloride, a sulfate, or a nitrate by a conventional method, if necessary.

上記反応工程式Aにおける化合物(TV)は公知の化合
物であるが、化合物(1)は新規化合物である。化合物
(I[[)は、例えば下記反応工程式Bに従って製造で
きる。
Compound (TV) in the above reaction scheme A is a known compound, but compound (1) is a new compound. Compound (I[[) can be produced, for example, according to Reaction Scheme B below.

く反応工程式B〉 COOH     COOH      CI)(上記
一般式(Illb )中、X′はハロゲン原子を示す。
Reaction Scheme B> COOH COOH CI) (In the above general formula (Illb), X' represents a halogen atom.

〕 即ち、式(V)で表わされる公知化合物であるp−メト
キシフェニルピルビン酸をアセチル化して化合物(II
I)の内Xが水酸基である化合物(Ia )を得る。次
いで、これをハロゲン化して化合物(II[)の内Xが
ハロゲン原子である化合物CI[[b )を得る。
] That is, p-methoxyphenylpyruvic acid, which is a known compound represented by formula (V), is acetylated to form compound (II
A compound (Ia) in which X in I) is a hydroxyl group is obtained. Next, this is halogenated to obtain compound CI[[b 2 ] in which X in compound (II[) is a halogen atom.

上記アセチル化反応は、アセチル化剤として、例えば無
水酢酸、塩化アセチル等を用い、アセチル化剤をそのま
ま溶媒としても用いるか又は前記非プロトン性溶媒中で
、行なわれる。アセチル化剤の使用量は、化合物(V)
に対して通常0.5倍モル以上、好ましくは等倍モル以
上とするのが良い。反応は、無触媒下でも進行するが、
反応の際、例えばp−トルエンスルホン酸等の触媒を、
化合物(V)に対して0.1〜10%程度使用するのが
好ましい。反応温度は、特に限定されないが、通常O〜
200℃程度とすれば良い。反応時間は、通常30分〜
24時間程度である。
The above acetylation reaction is carried out using, for example, acetic anhydride, acetyl chloride, etc. as the acetylating agent, and using the acetylating agent as it is as a solvent, or in the aprotic solvent described above. The amount of acetylating agent used is compound (V)
The amount is usually 0.5 times or more, preferably 1 times or more by mole. The reaction proceeds even without a catalyst, but
During the reaction, a catalyst such as p-toluenesulfonic acid,
It is preferably used in an amount of about 0.1 to 10% based on compound (V). The reaction temperature is not particularly limited, but is usually O~
The temperature may be about 200°C. Reaction time is usually 30 minutes ~
It takes about 24 hours.

また、上記ハロゲン化反応は、ハロゲン化剤として、例
えばオキサリルクロライド、チオニルクロライド、オキ
シ塩化燐、オキサリルブロマイド等を用い、ハロゲン化
剤をそのまま溶媒としても用いるか又は前記非プロトン
性溶媒中で、行なわれる。ハロゲン化剤の使用量は、化
合物(Ia )に対して通常0.2倍モル程度以上、好
ましくは0.5倍モル以上とするのが良い。反応温度は
、特に限定されないが、通常O〜200℃程度とすれば
良い。反応時間は、通常10分〜12時間程度である。
Further, the above halogenation reaction is carried out using, for example, oxalyl chloride, thionyl chloride, phosphorus oxychloride, oxalyl bromide, etc. as a halogenating agent, and using the halogenating agent as it is as a solvent, or in the aprotic solvent described above. It will be done. The amount of the halogenating agent to be used is usually about 0.2 times or more, preferably 0.5 times or more by mole, relative to compound (Ia). The reaction temperature is not particularly limited, but may be generally about 0 to 200°C. The reaction time is usually about 10 minutes to 12 hours.

かくして、化合物(II[)が得られ、これを前記反応
工程式Aの原料とする。
In this way, compound (II[) is obtained, which is used as the starting material for reaction scheme A above.

本発明のケイ皮酸アミド誘導体を閉環して化合物(II
)とする反応は、例えば、適当な溶媒中、通常1〜10
時市程度、通常50〜150℃程度の温度に加熱するこ
とにより行なわれる1反応は、前記不活性雰囲気中で行
なうのが好ましい。溶媒としては、例えばクロロホルム
、ジクロルエタン、1.1.1−トリクロルエタン、1
.1.2−トリクロルエタン、テトラクロルエタン等の
ハロゲン化炭化水素、エタノール、プロパツール、ブタ
ノール等のアルコール、ベンゼン、トルエン、キシレン
等の芳香族炭化水素等を挙げることができ、これらの少
なくとも1種を用いる。
The cinnamic acid amide derivative of the present invention is ring-closed to form the compound (II
), for example, in an appropriate solvent, usually with a reaction time of 1 to 10
One reaction carried out by heating to a temperature of approximately 50° C. to 150° C. is preferably carried out in the above-mentioned inert atmosphere. Examples of the solvent include chloroform, dichloroethane, 1.1.1-trichloroethane, 1.
.. 1. At least one of halogenated hydrocarbons such as 2-trichloroethane and tetrachloroethane, alcohols such as ethanol, propatool, and butanol, and aromatic hydrocarbons such as benzene, toluene, and xylene. Use.

本発明によれば、化合物(II)の製造中間体として有
用な新規化合物CI)及びその酸付加塩、並びにこれら
を簡便且つ高収率で得る方法が提供される。
According to the present invention, there are provided a novel compound CI) useful as an intermediate for the production of compound (II), an acid addition salt thereof, and a method for obtaining them simply and in high yield.

LLfLL工ヌ」口1 以下、参考例及び実施例を挙げて、本発明を更に具体的
に説明する。
EXAMPLE 1 The present invention will be described in more detail below with reference to reference examples and examples.

参考例1 p−メトキシ−α−アセトキシケイ皮酸の合成p−メト
キシフェニルピルビンWI2Qを無水酢115−に懸濁
し、D−トルエンスルホン酸0.1gを加え、撹拌下2
時間還流した。反応終了後、冷却し析出する結晶を枦取
し、酢酸エチル洗浄後乾燥した。収量2g (収率82
.2%)、■、p。
Reference Example 1 Synthesis of p-methoxy-α-acetoxycinnamic acid p-methoxyphenylpyruvin WI2Q was suspended in anhydrous vinegar 115-, 0.1 g of D-toluenesulfonic acid was added, and the mixture was stirred for 2 hours.
Refluxed for an hour. After the reaction was completed, the mixture was cooled, and the precipitated crystals were collected, washed with ethyl acetate, and then dried. Yield 2g (yield 82
.. 2%), ■, p.

180〜181℃、黄色結晶。180-181°C, yellow crystals.

I R(am−’ ) : 1765 (−C−C−0−Go−)、1710(−C
OOH)。
I R (am-'): 1765 (-C-C-0-Go-), 1710 (-C
OOH).

元素分析値:c+ 2 H120sとして計算値(%)
C:61.01、H:5.12、実験値(%)C:61
.11、H:5.15゜参考例2 p−メトキシ−α−7セトキシケイ皮酸クロライドの合
成 p−メトキシ−α−7セトキシケイ皮酸3gをオキサリ
ルクロライド10Ii2に加え、撹拌下40分間還流し
た。反応終了後、反応液を減圧にて濃縮した。更に、残
存するオキサリルクロライドを除去するために塩化メチ
レンを加え、再度、減圧で濃縮した。残渣にn−ヘキサ
ンを加えて結晶化させ、結晶を枦取した。収量2.60
  (収率80%) 、1.9.124〜127℃(分
解)、赤色針状結晶。
Elemental analysis value: Calculated value (%) as c+ 2 H120s
C: 61.01, H: 5.12, Experimental value (%) C: 61
.. 11, H: 5.15° Reference Example 2 Synthesis of p-methoxy-α-7-setoxycinnamic acid 3 g of p-methoxy-α-7-setoxycinnamic acid was added to oxalyl chloride 10Ii2, and the mixture was refluxed for 40 minutes with stirring. After the reaction was completed, the reaction solution was concentrated under reduced pressure. Furthermore, methylene chloride was added to remove residual oxalyl chloride, and the mixture was again concentrated under reduced pressure. N-hexane was added to the residue to crystallize it, and the crystals were collected. Yield 2.60
(yield 80%), 1.9.124-127°C (decomposition), red needle-like crystals.

IR(c−4): 1810 (−COCl2 )。IR (c-4): 1810 (-COCl2).

元素分析値:Ct 2 H+ t e120A トシテ
計算値(%)C:56.59、H:4.35、実験値(
%)C:56.70、H:4.40゜実施例1 N−(2−ジメチルアミンエチル)−N−(o−メルカ
プトフェニル トキシケイ皮酸アミド及びその塩酸塩の合成p−メトキ
シ−α−7セトキシケイ皮111. 29とN.N’ 
−ジシクロへキシルカルボジイミド1、1gとをクロロ
ホルム35−に溶解し、窒素気流中N瀉下で撹拌した。
Elemental analysis value: Ct 2 H + t e120A Toshite calculated value (%) C: 56.59, H: 4.35, experimental value (
%) C: 56.70, H: 4.40゜Example 1 Synthesis of N-(2-dimethylamineethyl)-N-(o-mercaptophenyltoxycinnamic acid amide and its hydrochloride p-methoxy-α -7 Setoxysilica 111.29 and N.N'
1.1 g of -dicyclohexylcarbodiimide was dissolved in chloroform (35-), and the mixture was stirred under nitrogen in a nitrogen stream.

3時間後、これにり0ロホルム20112に溶解した2
−N−(2−ジメチルアミノエチル)アミノチオフェノ
ール1.0gを窒素気流中撹拌下に室温で加えた。更に
、12時間撹拌し、反応終了後、析出した沈澱を枦去し
クロロホルムで洗った。反応液を冷水で洗浄後、芒硝に
より乾燥し、減圧で濃縮℃てN−(2−ジメチルアミノ
エチル)−N−(0−メルカプトフェニル)−p−メト
キシ−α−アセトキシケイ皮酸アミドを得た。収量1.
90(収率90.4%)、淡黄色粘稠性油状物。
After 3 hours, this was followed by 2 dissolved in 0roform 20112.
1.0 g of -N-(2-dimethylaminoethyl)aminothiophenol was added at room temperature under stirring in a nitrogen stream. The mixture was further stirred for 12 hours, and after the reaction was completed, the precipitate deposited was removed and washed with chloroform. The reaction solution was washed with cold water, dried with Glauber's salt, and concentrated under reduced pressure at °C to obtain N-(2-dimethylaminoethyl)-N-(0-mercaptophenyl)-p-methoxy-α-acetoxycinnamic acid amide. Ta. Yield 1.
90 (yield 90.4%), pale yellow viscous oil.

I R(cm−’ ) : 1760 (−C−C−0−Co−)、1635 (C
−C−Go−N−C−C)。
IR (cm-'): 1760 (-C-C-0-Co-), 1635 (C
-C-Go-N-C-C).

NMR(DMSO−d s 、δ): 1.90 (3H,S 、−COO比し)、2.22 
(6H,s 、−N (CLLLL>、2.85〜3.
50 (5H,s 。
NMR (DMSO-ds, δ): 1.90 (3H,S, -COO ratio), 2.22
(6H,s, -N (CLLL>, 2.85-3.
50 (5H, s.

−CLLCLLNく及び−8H)、 3 、79 (3H,S 、  QCLL)、6.65
〜8.10(9H,m。
-CLLCLLN and -8H), 3, 79 (3H,S, QCLL), 6.65
~8.10 (9H, m.

芳香族性H及び−CL−C< )。Aromatic H and -CL-C< ).

これをエタノールに溶解させ、塩酸・エタノールを加え
放置して塩酸塩を析出させた。これを枦取、乾燥した。
This was dissolved in ethanol, and hydrochloric acid and ethanol were added and allowed to stand to precipitate the hydrochloride. This was taken out and dried.

収量1.9a(収率78%)、吸湿性の黄褐色固体。Yield 1.9a (78% yield), hygroscopic tan solid.

IR(am″): 2600〜2300 (NH4)、 1755.1670 (C−0)。IR(am″): 2600-2300 (NH4), 1755.1670 (C-0).

NMR(CHa 0H−d 、、δ):2.00 (3
H,s 、−COC比L)、2.93 (6H,S 、
−N (CLLLL)、3.18〜3.83 (4H,
m 。
NMR (CHa 0H-d,, δ): 2.00 (3
H,s, -COC ratio L), 2.93 (6H,S,
-N (CLLLLL), 3.18-3.83 (4H,
m.

−CLLCLLNく)、 3.79 (3H,S 、  0CLL)、6 、 4
8〜7.   75   (9H,鵬  。
-CLLCLLN), 3.79 (3H, S, 0CLL), 6, 4
8-7. 75 (9H, Peng.

芳香族性H及び−〇H−C<)。Aromatic H and -〇H-C<).

実施例2 N−(2−ジメチルアミノエチル) −N−(o −メ
ルカプトフェニル)−p−メトキシ−α−7セトキシケ
イ皮酸アミド・塩酸塩の合成 p−メトキシ−α−アセトキシケイ皮酸クロライド2g
を1.1.2−ト)’)CJ)Ltエタン20w1tに
溶解した。これを窒素ガス気流下で1.1.2−トリク
ロルエタン40−に11解した2−N−(2−ジメチル
アミノエチル)アミノチオフェノール1.55a中に撹
拌下、−10℃以下に保って加えた。更に一10’C以
下に保ちながら3時間撹拌した。その後、空温下で12
時間撹拌した。
Example 2 Synthesis of N-(2-dimethylaminoethyl)-N-(o-mercaptophenyl)-p-methoxy-α-7cetoxycinnamic acid amide hydrochloride 2 g of p-methoxy-α-acetoxycinnamic acid chloride
1.1.2-t)')CJ)Lt was dissolved in 20w1t of ethane. This was added to 2-N-(2-dimethylaminoethyl)aminothiophenol 1.55a dissolved in 1.1.2-trichloroethane 40-11 under a stream of nitrogen gas and kept at -10°C or lower with stirring. added. The mixture was further stirred for 3 hours while maintaining the temperature below -10'C. After that, under air temperature for 12
Stir for hours.

反応終了後、反応液中に析出した結晶を枦取し、エーテ
ル洗浄後、イソプロピルアルコール・エーテルから再結
晶した。収量3g (収率87%)、吸湿性の黄褐色固
体。
After the reaction was completed, the crystals precipitated in the reaction solution were collected, washed with ether, and then recrystallized from isopropyl alcohol/ether. Yield: 3 g (87% yield), hygroscopic tan solid.

このもののIR及びNMRg5データーは、実施。IR and NMRg5 data for this product were obtained.

例1で得たものと一致した。It was consistent with that obtained in Example 1.

参考例3 2−(4−メトキシフェニル)−3−7セトキシー5−
 (2−ジメチルアミノエチル)−2,3−ジヒドロ−
1,5−ベンゾチアゼピン−4(5H)−オン・塩酸塩
の合成 N−(2−ジメチルアミノエチル) −N=(0−メル
カプトフェニル)−p−メトキシ−α−7セトキシケイ
皮酸アミド・塩酸塩1.9gに1゜1.2−トリクロル
エタン25mを加え、窒素気流中、撹拌下6時間還流し
た。その後、反応液を減圧下に濃縮した。この濃縮残!
l[(粘稠性固体)をエタノールから再結晶して2−(
4−メトキシフェニル)−3−アセトキシ−5−(2−
ジメチルアミノエチル)−2,3−ジヒドロ−1,5−
ベンゾチアゼピン−4(5H)−オン・塩酸塩を得た。
Reference example 3 2-(4-methoxyphenyl)-3-7 setoxy 5-
(2-dimethylaminoethyl)-2,3-dihydro-
Synthesis of 1,5-benzothiazepin-4(5H)-one hydrochloride N-(2-dimethylaminoethyl) -N=(0-mercaptophenyl)-p-methoxy-α-7setoxycinnamic acid amide. 25 m of 1°1.2-trichloroethane was added to 1.9 g of the hydrochloride, and the mixture was refluxed for 6 hours with stirring in a nitrogen stream. Thereafter, the reaction solution was concentrated under reduced pressure. This concentrated residue!
Recrystallize l[(viscous solid) from ethanol to obtain 2-(
4-methoxyphenyl)-3-acetoxy-5-(2-
dimethylaminoethyl)-2,3-dihydro-1,5-
Benzothiazepine-4(5H)-one hydrochloride was obtained.

収量1.50(収率78.9%)、白色結晶、■、p、
185〜188℃。
Yield 1.50 (yield 78.9%), white crystals, ■, p,
185-188°C.

IR(CI″′): 1740.1213 (COCH3)、1680 (−
Go−N<)、 1250.1028 (C−8)。
IR (CI″′): 1740.1213 (COCH3), 1680 (-
Go-N<), 1250.1028 (C-8).

NMR(DMSO−d 8 、δ): 1.89 (3H,s 、   C0CLL)、2、7
0〜3.05 (6H,broad 。
NMR (DMSO-d8, δ): 1.89 (3H,s, C0CLL), 2,7
0-3.05 (6H, broad.

−N(CLLLL)、 3.10〜3.63 (2H,m 。-N(CLLLLL), 3.10-3.63 (2H, m.

−〇 HN < )、 3.82(3H,s、   0CLL)、4.10〜4
.75  (2H,m  。
-〇 HN < ), 3.82 (3H, s, 0CLL), 4.10~4
.. 75 (2H, m.

−C旦ニー−)、 4.99  (1H,d 、J−7H2。-C Dannie-), 4.99 (1H, d, J-7H2.

−8−OH<)、 5.15  (1H,d  、J−7Hz  。-8-OH<), 5.15 (1H, d, J-7Hz.

>CH−OCOCHa  )  、 6.70〜7.82  (8H,■ 。>CH-OCOCHa), 6.70-7.82 (8H,■.

芳香族性H)。Aromaticity H).

(以 上)(that's all)

Claims (2)

【特許請求の範囲】[Claims] (1)式 ▲数式、化学式、表等があります▼ で表わされるN−(2−ジメチルアミノエチル)−N−
(o−メルカプトフェニル)−p−メトキシ−α−アセ
トキシケイ皮酸アミド及びその酸付加塩であるケイ皮酸
アミド誘導体。
(1) N-(2-dimethylaminoethyl)-N- represented by the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼
(o-Mercaptophenyl)-p-methoxy-α-acetoxycinnamic acid amide and its acid addition salt, cinnamic acid amide derivative.
(2)一般式 ▲数式、化学式、表等があります▼ 〔式中、Xは水酸基又はハロゲン原子を示す。〕で表わ
される化合物と式 ▲数式、化学式、表等があります▼ で表わされる2−N−(2−ジメチルアミノエチル)ア
ミノチオフェノールとを、脱水縮合反応又は脱ハロゲン
化水素反応に付して式 ▲数式、化学式、表等があります▼ で表わされるN−(2−ジメチルアミノエチル)−N−
(o−メルカプトフェニル)−p−メトキシ−α−アセ
トキシケイ皮酸アミドを得、更に必要に応じて酸付加塩
とすることを特徴とするケイ皮酸アミド誘導体の製造法
(2) General formula ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ [In the formula, X represents a hydroxyl group or a halogen atom. ] and 2-N-(2-dimethylaminoethyl)aminothiophenol represented by the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ are subjected to a dehydration condensation reaction or a dehydrohalogenation reaction. N-(2-dimethylaminoethyl)-N- represented by the formula ▲Mathematical formulas, chemical formulas, tables, etc.▼
A method for producing a cinnamic acid amide derivative, which comprises obtaining (o-mercaptophenyl)-p-methoxy-α-acetoxycinnamic acid amide and further converting it into an acid addition salt if necessary.
JP650385A 1985-01-16 1985-01-16 Cinnamic acid amide derivative and production thereof Pending JPS61165363A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP650385A JPS61165363A (en) 1985-01-16 1985-01-16 Cinnamic acid amide derivative and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP650385A JPS61165363A (en) 1985-01-16 1985-01-16 Cinnamic acid amide derivative and production thereof

Publications (1)

Publication Number Publication Date
JPS61165363A true JPS61165363A (en) 1986-07-26

Family

ID=11640236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP650385A Pending JPS61165363A (en) 1985-01-16 1985-01-16 Cinnamic acid amide derivative and production thereof

Country Status (1)

Country Link
JP (1) JPS61165363A (en)

Similar Documents

Publication Publication Date Title
JP4667691B2 (en) Process for the preparation of nitroxyalkyl esters of naproxen
JP2004534063A (en) Preparation of mycophenolate mofetil
EP0080819B1 (en) 11-0-alkylerythromycin a derivatives
SU728712A3 (en) Method of preparing cinnamoyl amide
JPS61165363A (en) Cinnamic acid amide derivative and production thereof
CN112272665B (en) Process for preparing ritalst
WO1998032736A1 (en) Process for producing benzylsuccinic acid derivatives
JPH0521105B2 (en)
JPH02138243A (en) Tranilast intermediate product and preparation thereof
JP3193597B2 (en) Method for producing glycine derivative
JP5234856B2 (en) Crystal of compound having NPYY5 receptor antagonistic action
JP3241741B2 (en) &#34;Method for producing 3- (7-amidino-2-naphthyl) -2-phenylpropionic acid derivative&#34;
JP3523921B2 (en) Azaspiro derivative and method for producing the same
JPS61165378A (en) Production of benzothiazepine derivative
US4997972A (en) 2-acylamino-5-halogenated-cinnamic acid derivative and method for its production
JP4311889B2 (en) Method for producing (meth) acrylic anhydride
JP3074665B2 (en) Method for producing novel hydrazone compounds and triazole compounds
JP2980992B2 (en) Method for producing 6-halogeno-2-oxapregna-4,6-dien-3-one compound
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
KR100445781B1 (en) Process for preparing (S)-1-acetyl-2-pyrrolidinecarboxamide
JP3538889B2 (en) Method for producing alkylthioacetamide
JPS58172399A (en) Muramyl tripeptide derivative
JP3655311B2 (en) Method for producing phthalide compound
JPH07285921A (en) Production of 2-amino-n-(beta-hydroxyphenethyl)acetamide derivative
JPS61158962A (en) Production of 1,4-dihydropyridine derivative